Cargando…

Combination Immune Checkpoint Blockade Regimens for Previously Untreated Metastatic Renal Cell Carcinoma: The Winship Cancer Institute of Emory University Experience

INTRODUCTION: There are three combination immune checkpoint inhibitor (ICI)–based regimens in the first-line setting for metastatic renal cell carcinoma (mRCC). Currently, there is limited real-world data for clinical outcomes and toxicity in mRCC patients treated with first-line ICI-based regimens....

Descripción completa

Detalles Bibliográficos
Autores principales:	Martini, Dylan J., Olsen, T. Anders, Goyal, Subir, Liu, Yuan, Evans, Sean T., Hitron, Emilie Elise, Russler, Greta Anne, Yantorni, Lauren, Caulfield, Sarah, Brown, Jacqueline T., Goldman, Jamie M., Nazha, Bassel, Carthon, Bradley C., Harris, Wayne B., Kucuk, Omer, Master, Viraj A, Bilen, Mehmet Asim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Innovative Healthcare Institute 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9390705/ https://www.ncbi.nlm.nih.gov/pubmed/36034580 http://dx.doi.org/10.36401/JIPO-22-2

Ejemplares similares

Racial Differences in Clinical Outcomes for Metastatic Renal Cell Carcinoma Patients Treated With Immune-Checkpoint Blockade
por: Olsen, T. Anders, et al.
Publicado: (2021)

Baseline Neutrophil-to-Eosinophil Ratio Is Associated with Outcomes in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors
por: Zhuang, Tony Z, et al.
Publicado: (2022)

Body Composition Variables as Radiographic Biomarkers of Clinical Outcomes in Metastatic Renal Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors
por: Martini, Dylan J., et al.
Publicado: (2021)

Modified Glasgow Prognostic Score associated with survival in metastatic renal cell carcinoma treated with immune checkpoint inhibitors
por: Brown, Jacqueline T, et al.
Publicado: (2021)

Novel Risk Scoring System for Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors
por: Martini, Dylan J., et al.
Publicado: (2019)

Durable complete response for oligometastatic renal cell carcinoma with immune checkpoint inhibition and cytoreductive nephrectomy in a Jehovah’s witness: A case report
por: Zhuang, Tony Zibo, et al.
Publicado: (2022)

Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitors
por: Shabto, Julie M., et al.
Publicado: (2020)

Blood-Based Next-Generation Sequencing in Adrenocortical Carcinoma
por: Nazha, Bassel, et al.
Publicado: (2022)

Advances in Knowledge and Management of Immune-Related Adverse Events in Cancer Immunotherapy
por: Olsen, T. Anders, et al.
Publicado: (2022)

Early career interview: Amy Winship
por: Winship, Amy
Publicado: (2019)

Detection of Microsatellite Instability via Circulating Tumor DNA and Response to Immunotherapy in Metastatic Castration-Resistant Prostate Cancer: A Case Series
por: Ravindranathan, Deepak, et al.
Publicado: (2021)

Metastatic Prostate Cancer Manifesting as Cholestatic Jaundice: A Case Report and Review of the Literature
por: Ravindranathan, Deepak, et al.
Publicado: (2018)

Metastatic Clear-Cell Renal Cell Carcinoma in the Era of Immune Checkpoint Inhibitors: Therapies and Ongoing Trials
por: Zhuang, Tony Zibo, et al.
Publicado: (2022)

Ramucirumab and Docetaxel in Patients with Metastatic Urothelial Carcinoma Harboring Fibroblast Growth Factor Receptor Alterations: A Case Series and Literature Review
por: Smith, Katherine Emilie Rhoades, et al.
Publicado: (2020)

Dr. Emory C. Abbey
Publicado: (1902)

Inflammatory Markers in Cancer Immunotherapy
por: Ravindranathan, Deepak, et al.
Publicado: (2021)

Cohort profile: the Emory Cardiovascular Biobank (EmCAB)
por: Ko, Yi-An, et al.
Publicado: (2017)

Sheltered Neurosurgery During COVID-19: The Emory Experience
por: Saad, Hassan, et al.
Publicado: (2020)

Neoadjuvant Nivolumab and Ipilimumab for Nonmetastatic Renal Cell Carcinoma with Tumor Thrombus
por: Master, Viraj A., et al.
Publicado: (2022)

Neoadjuvant Cabozantinib in an Unresectable Locally Advanced Renal Cell Carcinoma Patient Leads to Downsizing of Tumor Enabling Surgical Resection: A Case Report
por: Bilen, Mehmet A., et al.
Publicado: (2021)

The Emory-Tibet Science Initiative: Rethinking Cross-Cultural Science and Teaching
por: Gray, Kelsey Marie, et al.
Publicado: (2019)

The Exposome Paradigm in Human Health: Lessons from the Emory Exposome Summer Course
por: Niedzwiecki, Megan M., et al.
Publicado: (2017)

Case Report: Exceptional Response to Nivolumab Plus Ipilimumab in a Young Woman With TFE3-SFPQ Fusion Translocation-Associated Renal Cell Carcinoma
por: Martini, Dylan J., et al.
Publicado: (2021)

Prognostic Evaluation of Metastatic Castration Resistant Prostate Cancer and Neuroendocrine Prostate Cancer with [(68)Ga]Ga DOTATATE PET-CT
por: Bilen, Mehmet Asim, et al.
Publicado: (2022)

Emory Roybal Center for Dementia Caregiving Mastery: Diverse Responses to Letter of Intent Call
por: Hepburn, Kenneth, et al.
Publicado: (2020)

Whole-exome sequencing prioritizes candidate genes for hereditary cataract in the Emory mouse mutant
por: Bennett, Thomas M, et al.
Publicado: (2023)

Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapy
por: Bilen, Mehmet Asim, et al.
Publicado: (2019)

The Emory Center for Injury Control: Vision and Priorities for Reducing Violence and Injuries through Interdisciplinary Collaborations
por: Houry, Debra, et al.
Publicado: (2010)

BMP and Beyond: A 25-Year Historical Review of Translational Spine Research at Emory University
por: Presciutti, Steven, et al.
Publicado: (2018)

Protocol for the Emory University African American maternal stress and infant gut microbiome cohort study
por: Brennan, Patricia A., et al.
Publicado: (2019)

Protocol for the Emory University African American Vaginal, Oral, and Gut Microbiome in Pregnancy Cohort Study
por: Corwin, Elizabeth J., et al.
Publicado: (2017)

Validation of the Emory Risk Score in the Transcatheter Aortic Valve Implantation Population: A Canadian Perspective
por: Hyde, Emily K., et al.
Publicado: (2022)

A novel preoperative inflammatory marker prognostic score in patients with localized and metastatic renal cell carcinoma
por: Sekar, Rishi R., et al.
Publicado: (2017)

Promoting Undergraduate Interest, Preparedness, and Professional Pursuit in the Sciences: An Outcomes Evaluation of the SURE Program at Emory University
por: Junge, Benjamin, et al.
Publicado: (2010)

Assessing Treatment-Resistant Posttraumatic Stress Disorder: The Emory Treatment Resistance Interview for PTSD (E-TRIP)
por: Dunlop, Boadie W., et al.
Publicado: (2014)

Correction to: Protocol for the Emory University African American Vaginal, oral, and gut microbiome in pregnancy cohort study
por: Corwin, Elizabeth J., et al.
Publicado: (2017)

UNC-Emory Infant Atlases for Macaque Brain Image Analysis: Postnatal Brain Development through 12 Months
por: Shi, Yundi, et al.
Publicado: (2017)

Broadening Our Scope: A Pilot Curriculum in Bioethics for Pathology Graduate Medical Trainees, the Emory University Experience
por: Perkins, Ifeoma U., et al.
Publicado: (2019)

Symptomatic methemoglobinemia in a patient with metastatic clear cell renal cell carcinoma treated with pembrolizumab and axitinib combination therapy: a case report
por: Olsen, T. Anders, et al.
Publicado: (2021)

2784. Rates of Susceptibility and Heteroresistance to Novel Antibiotic Combinations in Carbapenem-Resistant Enterobacterales Isolates - Emory Healthcare, 2016-2021
por: Lin, Christina K, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6ms0sbtq2f61n06pdg8la1p5m0